CMMB insider filings

Chemomab Therapeutics Ltd. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-01. Screen CMMB transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Cohen Neil Harris — Director1—2 legs · 2,304 sh · $6,5167

Recent insider filings — Chemomab Therapeutics Ltd.

FiledFormInsiderReported transactionsSource
2026-09-014Cohen Neil Harris — DirectorSale (S): 1,304 @ $2.85 · Sale (S): 1,000 @ $2.80 · Grant/award (A): 172 (derivative) @ $0 · Grant/award (A): 2,971 (derivative) @ $0 · Grant/award (A): 1,705 (derivative) @ $0 · Grant/award (A): 1,714 (derivative) @ $0 · +3 moreEDGAR
2026-06-014Mor George Adi — Chief Executive Officer, DirectorPurchase (P): 4,878 @ $2.05 · Purchase (P): 4,926 @ $2.08 · Other (J): 31,712 · Other (J): 18,750EDGAR
2023-07-054Darvish Nissim — DirectorGrant/award (A): 20,572 (derivative) @ $0 · Grant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 10,123 (derivative) @ $0EDGAR
2023-06-204Quigley Jill M. — DirectorGrant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 13,640 (derivative) @ $0EDGAR
2023-06-164Fatal Sigal — Chief Financial OfficerGrant/award (A): 102,860 (derivative) @ $0 · Grant/award (A): 29,400 (derivative) @ $0 · Grant/award (A): 35,600 (derivative) @ $0EDGAR
2023-03-234Moses Alan Charles — DirectorGrant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2023-03-234Nicaise Claude — DirectorGrant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2023-03-234Cohen Neil Harris — DirectorGrant/award (A): 6,875 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2023-03-234Darvish Nissim — DirectorGrant/award (A): 6,857 (derivative) @ $0 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 10,123 (derivative) @ $0EDGAR
2023-01-054Mor George Adi — Chief Scientific Officer, DirectorSale (S): 7,700 @ $5.03 · Sale (S): 6,100 @ $5.03 · Grant/award (A): 131,698 (derivative) @ $0 · Grant/award (A): 33,725 (derivative) @ $0EDGAR
2023-01-054OrbiMed Israel GP Ltd. — 10% owner
OrbiMed Israel BioFund GP Limited Partnership — 10% owner
Sale (S): 266,376 @ $3.34 · Sale (S): 70,524 @ $4.51EDGAR
2022-11-184Cohen Neil Harris — DirectorSale (S): 2,409 @ $2 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-11-174Mor George Adi — Chief Scientific Officer, DirectorSale (S): 324,775 @ $2.08 · Sale (S): 257,248 @ $2.08 · Grant/award (A): 131,698 (derivative) @ $0 · Grant/award (A): 33,725 (derivative) @ $0EDGAR
2022-06-214Marvin Donald — Executive VP, CFO & COOPurchase (P): 250 @ $3.30 · Purchase (P): 250 @ $3.25 · Grant/award (A): 196,875 (derivative) @ $0EDGAR
2022-05-254Maryles Joel Michael — DirectorPurchase (P): 400 @ $2.89 · Purchase (P): 33 @ $2.76 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2022-05-194Cohen Neil Harris — DirectorPurchase (P): 2,000 @ $3.19 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-03-214Maryles Joel Michael — DirectorPurchase (P): 500 @ $4.32 · Purchase (P): 500 @ $4.36 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2022-03-214Marvin Donald — Executive VP, CFO & COOPurchase (P): 250 @ $4 · Purchase (P): 250 @ $3.98 · Purchase (P): 250 @ $3.90 · Purchase (P): 250 @ $4.10 · Purchase (P): 250 @ $4.20 · Grant/award (A): 196,875 (derivative) @ $0EDGAR
2022-03-154Cohen Neil Harris — DirectorPurchase (P): 2,000 @ $4.20 · Purchase (P): 2,000 @ $4.30 · Purchase (P): 2,000 @ $4.56 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 688 (derivative) @ $0EDGAR
2022-03-154Pfost Dale R — Chief Executive Officer, DirectorPurchase (P): 1,800 @ $3.98 · Purchase (P): 700 @ $3.97 · Grant/award (A): 459,353 (derivative) @ $0EDGAR
2022-03-144Darvish Nissim — DirectorPurchase (P): 1,200 @ $4.28 · Grant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0 · Grant/award (A): 10,123 (derivative) @ $0EDGAR
2022-03-094Darvish Nissim — DirectorGrant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2022-03-094Nicaise Claude — DirectorGrant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2022-03-094Cohen Neil Harris — DirectorGrant/award (A): 6,820 (derivative) @ $0EDGAR
2022-03-094Moses Alan Charles — DirectorGrant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2022-03-094Maryles Joel Michael — DirectorGrant/award (A): 6,820 (derivative) @ $0 · Grant/award (A): 11,884 (derivative) @ $0EDGAR
2021-12-084Cohen Neil Harris — DirectorPurchase (P): 2,000 @ $7.43EDGAR
2021-05-104Fatal Sigal — Chief Financial OfficerGrant/award (A): 35,653 (derivative) @ $0EDGAR
2021-04-214Nicaise Claude — DirectorGrant/award (A): 11,884 (derivative) @ $0EDGAR
2021-04-214Moses Alan Charles — DirectorGrant/award (A): 11,884 (derivative) @ $0EDGAR
2021-04-214Maryles Joel Michael — DirectorGrant/award (A): 11,884 (derivative) @ $0EDGAR
2021-04-214Darvish Nissim — DirectorGrant/award (A): 11,884 (derivative) @ $0EDGAR
2021-04-214Cohen Neil Harris — DirectorGrant/award (A): 11,884 (derivative) @ $0EDGAR
2021-04-214SQUINTO STEPHEN P — DirectorGrant/award (A): 23,768 (derivative) @ $0EDGAR
2021-03-264Cohen Neil Harris — DirectorPurchase (P): 2,409 @ $41.51 · Purchase (P): 688 (derivative) @ $0EDGAR
2021-03-184OrbiMed Israel GP Ltd. — 10% owner
OrbiMed Israel BioFund GP Limited Partnership — 10% owner
Grant/award (A): 288,170 @ $17.35 · Grant/award (A): 28,817 (derivative)EDGAR
2021-03-184THIEL PETER — 10% ownerPurchase (P): 230,536 · Purchase (P): 23,054 (derivative)EDGAR

Recent 8-K events — Chemomab Therapeutics Ltd.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-06-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-218-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-298-K/A9.01 — Financial Statements and ExhibitsEDGAR
2022-11-168-K8.01 — Other EventsEDGAR
2022-11-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CMMB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs